Actinium Pharmaceuticals
ATNM
ATNM
62 hedge funds and large institutions have $7.66M invested in Actinium Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 11 increasing their positions, 22 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
-8
Holders Change %
-11.43%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
11
Reduced
22
Closed
26
Calls
$99K
Puts
$1K
Net Calls
+$98K
Net Calls Change
-$21K
Top Buyers
| 1 |
Millennium Management
New York
|
+$929K |
| 2 |
Jane Street
New York
|
+$306K |
| 3 |
Renaissance Technologies
New York
|
+$213K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$137K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$90.9K |
Top Sellers
| 1 |
BlackRock
New York
|
-$2.07M |
| 2 |
State Street
Boston,
Massachusetts
|
-$592K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$535K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$519K |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
-$376K |
